Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - fluvoxamine maleate, quantity: 50 mg - tablet, film coated - excipient ingredients: mannitol; maize starch; pregelatinised potato starch; colloidal anhydrous silica; hypromellose; macrogol 6000; purified talc; titanium dioxide; sodium stearylfumarate - movox (fluvoxamine maleate) is indicated for the treatment of major depression in adults. movox (fluvoxamine maleate) is also indicated for the treatment of obsessive compulsive disorder (ocd) in both children aged 8 years and older, adolescent, and adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - fluvoxamine maleate, quantity: 50 mg - tablet, film coated - excipient ingredients: mannitol; maize starch; pregelatinised potato starch; sodium stearylfumarate; colloidal anhydrous silica; hypromellose; macrogol 6000; purified talc; titanium dioxide - luvox (fluvoxamine maleate) is indicated for the treatment of: major depression in adults, and obsessive compulsive disorder (ocd) in both children aged 8 years and older and adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - fluvoxamine maleate, quantity: 100 mg - tablet, film coated - excipient ingredients: pregelatinised potato starch; titanium dioxide; mannitol; maize starch; macrogol 6000; sodium stearylfumarate; purified talc; hypromellose; colloidal anhydrous silica - luvox (fluvoxamine maleate) is indicated for the treatment of: major depression in adults. it is also indicated for the treatment of obsessive compulsive disorder (ocd) in children aged 8 years of age and older, adolescents and adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - fluvoxamine maleate, quantity: 50 mg - tablet, film coated - excipient ingredients: mannitol; colloidal anhydrous silica; titanium dioxide; pregelatinised potato starch; maize starch; purified talc; macrogol 6000; hypromellose; sodium stearylfumarate - luvox (fluvoxamine maleate) is indicated for the treatment of: major depression in adults. it is also indicated for the treatment of obsessive compulsive disorder (ocd) in children aged 8 years of age and older, adolescents and adults.

Malta - English - Medicines Authority

wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - fluvoxamine maleate - tablet - fluvoxamine maleate 100 mg - psychoanaleptics

Singapore - English - HSA (Health Sciences Authority)

pharmline marketing pte. ltd. - fluvoxamine maleate - tablet, film coated - 50 mg - fluvoxamine maleate 50 mg

United States - English - NLM (National Library of Medicine)

jazz pharmaceuticals, inc. - fluvoxamine maleate (unii: 5lgn83g74v) (fluvoxamine - unii:o4l1xpo44w) - fluvoxamine maleate 100 mg

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - fluvoxamine maleate - tablets - fluvoxamine maleate 100 mg - fluvoxamine - for the treatment of affective disorders characterized by persistent low mood, impaired psychomotor atctivities and psychomatic complaints including symptoms of depression. treatment of obsessive compulsive disorders (ocd).

Canada - English - Health Canada

teva canada limited - fluvoxamine maleate - tablet - 50mg - fluvoxamine maleate 50mg - selective-serotonin reuptake inhibitors

Canada - English - Health Canada

teva canada limited - fluvoxamine maleate - tablet - 100mg - fluvoxamine maleate 100mg - selective-serotonin reuptake inhibitors